Robb E. Wilentz

Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

Robb E. Wilentz, Christine A. Iacobuzio–Donahue, Pedram Argani et al. · PubMed · 2000 · 592 citations

Medicine, Oncology, Pathology +17

Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

Pedram Argani, Christine A. Iacobuzio–Donahue, Byungwoo Ryu et al. · PubMed · 2001 · 578 citations

Life Sciences, Molecular Biology, Oncology +13

Solid-Pseudopapillary Tumors of the Pancreas Are Genetically Distinct from Pancreatic Ductal Adenocarcinomas and Almost Always Harbor β-catenin Mutations

Susan C. Abraham, David S. Klimstra, Robb E. Wilentz et al. · American Journal Of Pathology · 2002 · 489 citations · Full text

Medicine, Oncology, Pathology +10

Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia

N. Tjarda van Heek, Alan K. Meeker, Scott E. Kern et al. · American Journal Of Pathology · 2002 · 364 citations

Medicine, Cancer Biology, Oncology +12

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression.

Robb E. Wilentz, Joseph Geradts, Robert Maynard et al. · PubMed · 1998 · 340 citations

Medicine, Oncology, Pathology +17